Who Exports Apixaban from India — 171 Suppliers Behind a $179.9M Market
India's apixaban export market is supplied by 171 active exporters who collectively shipped $179.9M across 4,492 shipments. MACLEODS PHARMACEUTICALS LTD leads with a 48.6% market share, followed by APOTEX RESEARCH PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 83.6% of total export value, reflecting a concentrated market structure.
Top Apixaban Exporters from India — Ranked by Export Value
MACLEODS PHARMACEUTICALS LTD is the leading apixaban exporter from India, holding a 48.6% share of the $179.9M market across 4,492 shipments from 171 exporters. The top 5 suppliers — MACLEODS PHARMACEUTICALS LTD, APOTEX RESEARCH PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, SANDOZ PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED — collectively control 83.6% of total export value, indicating a highly concentrated market. Individual shares are: MACLEODS PHARMACEUTICALS LTD (48.6%), APOTEX RESEARCH PRIVATE LIMITED (11.4%), INTAS PHARMACEUTICALS LIMITED (10.4%), SANDOZ PRIVATE LIMITED (8.7%), ZYDUS LIFESCIENCES LIMITED (4.5%).
Top Apixaban Exporters from India
Ranked by export value · 171 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD APIXABAN 5MG SUDAIR -SA (AS PEMSN LABS, APIXABAN 2.5MG SUDAAPIXABAN 2.5MG SUDAIR -SA (AS | $87.5M | 9 | 48.6% |
| 2 | APOTEX RESEARCH PRIVATE LIMITED PHARMA DRUGS AND MEDI RIVA-APIXABAN 5MGTARO APIXABAN TAB 5MG CD 180BTL (20196 PAPO-APIXABAN FCT 5MG 500 BTL 68198/77131 | $20.6M | 2 | 11.4% |
| 3 | INTAS PHARMACEUTICALS LIMITED MATERIAL NO. - 44100520 APIXABAN SDZ 5MG56FCT GBMATERIAL NO. - 44100520 APIXABAN SDZ 5MGAPIXABAN 5MG TAB 60 S SALE BRAINFARMA (A | $18.7M | 9 | 10.4% |
| 4 | SANDOZ PRIVATE LIMITED MATERIAL NO. - 44100520 APIXABAN SDZ 5MG56FCT GBMATERIAL NO. - 44100520 APIXABAN SDZ 5MGAPIXABAN 5MG TAB 60 S SALE BRAINFARMA (A | $15.6M | 8 | 8.7% |
| 5 | ZYDUS LIFESCIENCES LIMITED APIXABAN 5MG TAB 60 S SALE BRAINFARMA (AAPIXABAN 5MG TABLETS 60'S (APPENDIX 4R,APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R | $8.1M | 11 | 4.5% |
| 6 | NATCO PHARMA LIMITED APIXABAN 5MG TAB 60 S SALE BRAINFARMA (AAPIXABAN 5MG TABLETS 60'S (APPENDIX 4R,PHARMA DRUGS AND MEDI RIVA-APIXABAN 5MG | $5.1M | 7 | 2.8% |
| 7 | MICRO LABS LIMITED MATERIAL NO. - 44100520 APIXABAN SDZ 5MG56FCT GBMATERIAL NO. - 44100520 APIXABAN SDZ 5MGAPIXABAN SDZ 5MG 56FCT GB MATERIAL NO. -44100520 | $3.9M | 14 | 2.2% |
| 8 | UNISON PHARMACEUTICALS PRIVATE LIMITED PHARMA DRUGS AND MEDI RIVA-APIXABAN 5MGTARO APIXABAN TAB 5MG CD 180BTL (20196 PAPO-APIXABAN FCT 5MG 500 BTL 68198/77131 | $3.9M | 5 | 2.2% |
| 9 | EMCURE PHARMACEUTICALS LIMITED MATERIAL NO. - 44100520 APIXABAN SDZ 5MG56FCT GBMATERIAL NO. - 44100520 APIXABAN SDZ 5MGAPIXABAN SDZ 5MG 56FCT GB MATERIAL NO. -44100520 | $3.0M | 2 | 1.7% |
| 10 | MSN LABORATORIES PRIVATE LIMITED APIXABAN 5MG TAB 60 S SALE BRAINFARMA (AAPIXABAN 5MG TABLETS 60'S (APPENDIX 4R,APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R | $2.4M | 4 | 1.3% |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED PHARMA DRUGS AND MEDI RIVA-APIXABAN 5MGTARO APIXABAN TAB 5MG CD 180BTL (20196 PAPO-APIXABAN FCT 5MG 500 BTL 68198/77131 | $1.7M | 2 | 0.9% |
| 12 | SAVA HEALTHCARE LIMITED APIGAT 5MG 30 TAB APIXABANELIQUIS 5 TABAPIBAN 5MG 100 TAB APIXABAN | $1.4M | 1 | 0.8% |
| 13 | TORRENT PHARMACEUTICALS LTD APIXABAN TORRENT 5MG FILM-COATED TABLETSPHR DRUGS&MEDI APIXABAN 5MG 4X14T(ACCORDPHARMA DRUG&MED:APIXABAN 5MG 4X14TACCOR | $1.3M | 5 | 0.7% |
| 14 | MACLEODS PHARMACEUTICALS LIMITED APIXABAN 5MG SUDAIR -SA (AS PEMSN LABS, APIXABAN 2.5MG SUDAAPIXABAN 2.5MG SUDAIR -SA (AS | $1.1M | 2 | 0.6% |
| 15 | CADILA HEALTHCARE LIMITED APIXABAN 5MG TAB 60 S SALE BRAINFARMA (AAPIXABAN 5MG TABLETS 60'S (APPENDIX 4R,APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R | $1.0M | 5 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Apixaban exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Macleods Pharmaceuticals Limited | Not Listed | Yes, April 2024 | Yes | Not Found | WHO-GMP certified in April 2024; EU GMP compliant. |
| Micro Labs Limited | Not Listed | Yes, December 2022 | Yes | Not Found | WHO-GMP certified in December 2022; EU GMP compliant. |
| Intas Pharmaceuticals Limited | Not Listed | Not Found | Yes | Not Found | EU GMP compliant. |
| Zydus Lifesciences Limited | Not Listed | Not Found | Yes | Not Found | EU GMP compliant. |
| Cadila Pharmaceuticals Limited | Warning Letter, March 201 | Yes | Not Found | Not Found | Received FDA warning letter in March 2014; WHO-GMP certified. |
| Emcure Pharmaceuticals Limited | Not Listed | Not Found | Not Found | Not Found | No specific regulatory data found. |
| MSN Laboratories Private Limited | Not Listed | Not Found | Not Found | Not Found | No specific regulatory data found. |
| Natco Pharma Limited | Not Listed | Not Found | Not Found | Not Found | No specific regulatory data found. |
| Sun Pharmaceutical Industries Limited | Not Listed | Not Found | Not Found | Not Found | No specific regulatory data found. |
| Torrent Pharmaceuticals Ltd | Not Listed | Not Found | Not Found | Not Found | No specific regulatory data found. |
TransData Nexus reviewed the regulatory standing of 10 leading Apixaban exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 4 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Apixaban sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This cluster's robust infrastructure and focus on R&D make it a pivotal area for the production of complex molecules such as Apixaban.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and finished dosage forms. Companies like Zydus Lifesciences Limited, headquartered in Ahmedabad, play a significant role in this cluster. Zydus Lifesciences Limited accounted for $8.1 million (4.5%) of Apixaban exports during the 2022-2026 period. The region's well-established manufacturing facilities and regulatory compliance make it a key player in the global pharmaceutical supply chain.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region in Maharashtra serves as a crucial export gateway for pharmaceutical products. Sun Pharmaceutical Industries Limited, headquartered in Mumbai, is a prominent player in this cluster. While specific export figures for Apixaban are not detailed, the region's strategic location and port facilities facilitate significant pharmaceutical exports, including anticoagulants like Apixaban.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives and supportive government policies. This cluster hosts numerous small and medium-sized enterprises (SMEs) specializing in various pharmaceutical products. While specific data on Apixaban production in this region is limited, the area's cost advantages and infrastructure make it a potential site for manufacturing such drugs.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 83.6% of Apixaban exports, consider engaging with multiple suppliers across different clusters to mitigate risks associated with over-reliance on a few sources.
- Evaluate Cluster Specializations: Align sourcing strategies with the specific strengths of each cluster. For instance, source bulk APIs from Hyderabad and finished formulations from Ahmedabad-Vadodara to leverage regional expertise.
- Assess Regulatory Compliance: Ensure that selected suppliers comply with international regulatory standards, such as those set by the FDA, EMA, and WHO, to facilitate smoother market entry and reduce compliance risks.
- Monitor Export Trends: Regularly analyze export data and market dynamics to identify emerging suppliers and regions that could offer competitive advantages in terms of cost, quality, and reliability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Apixaban exporters from India
Zydus Lifesciences Limited — Zydus receives USFDA approval for prostate cancer drug
In October 2024, Zydus Lifesciences received approval from the U.S. Food and Drug Administration (USFDA) to manufacture enzalutamide tablets, an androgen receptor inhibitor used in the treatment of prostate cancer. The product will be manufactured at Zydus' facility in Ahmedabad. - IMPACT: This approval may enhance Zydus' manufacturing capabilities, potentially influencing its Apixaban production and export capacity.
Impact: This approval may enhance Zydus' manufacturing capabilities, potentially influencing its Apixaban production and export capacity.
Common Questions — Apixaban Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which apixaban supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MACLEODS PHARMACEUTICALS LTD leads with 85 recorded shipments worth $87.5M. APOTEX RESEARCH PRIVATE LIMITED (361 shipments) and INTAS PHARMACEUTICALS LIMITED (436 shipments) are also established high-volume exporters.
Q How many apixaban manufacturers are there in India?
India has 171 active apixaban exporters with a combined export market of $179.9M across 4,492 shipments to 98 countries. The top 5 suppliers hold 83.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for apixaban from India?
Average FOB unit price: $6.90 per unit, ranging from $0.01 to $4444.44. Average shipment value: $40.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 171 verified Indian exporters of Apixaban ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,492 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 98 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,492 Verified Shipments
171 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists